Graded exposure in vivo
BehavioralGraded exposure in vivo according to the protocol of de Jong et al. (2005)
NCT Number: NCT00625976
Background:
Research on the treatment of CRPS-I, as described in the Dutch evidence based treatment guidelines (Richtlijn Complex Regional Pain Syndrome type I, 2006), mainly showed improvement at the level of pain and coping with pain. Only little improvement in functional restoration was found. Research in other pain populations such al neck- and back-pain patients has shown that pain related fear contributes to the development of functional disability. GEXP in vivo which aims on systematically reducing fear of movement, shows promising results in CRPS-I patients (de Jong et al., 2005).
Objective:
The objective of the proposed project is to compare the effectivity of GEXP in vivo with that of standardized physiotherapy in CRPS-I patients with pain related fear.
Design:
The study concerns a single blinded, single center, randomized clinical trial. The treatment will be preceded by two pre-measures. After treatment there will be one post-measurement and 3, 6 and 12 month follow-up measurements.
Population:
The study population will consist of chronic CRPS-I patients between 18 and 65, with pain related fear (PHODA-LE-score ≥ 35 and PHODA-UE-score ≥ 32).
Intervention:
The two interventions that will be compared are GEXP in vivo (de Jong et al., 2005) and standardized physiotherapy according to the protocol of Oerlemans, Oostendorp, de Boo en Goris (1999). The GEXP in vivo comprises 17 sessions of one hour, the physiotherapy treatment of 34 sessions of 30 minutes. Both treatments will be given over a period of 17 weeks.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Graded exposure in vivo according to the protocol of de Jong et al. (2005)
Physiotherapy according to the protocol of Oerlemans, Oostendorp, de Boo and Goris (1999)
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Time frame: 2 times pre treatment, one time post treatment and at 3, 6 and 12 months follow-up
Maastricht University Medical Center
Other
The Effectivity of Graded Exposure in Vivo Versus Standardized Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I) Patients With Pain Related Fear: a Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06100107
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome Type I
View Trial DetailsNCT03377504
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome Type I
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07711392
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome Type I
View Trial DetailsNCT07210515
Autonomic Nervous System Diseases, Complex Regional Pain Syndrome Type I
Phoenix, Arizona, United States
View Trial Details